Epigenetic deregulation in pediatric acute lymphoblastic leukemia

Area of Science:

• Genomics
• Epigenetics
• Pediatric Oncology

Background:

• Genome-wide DNA methylation profiles are frequently altered in pediatric acute lymphoblastic leukemia (ALL).
• A significant proportion of these methylation alterations do not correlate with changes in gene expression.
• Understanding these epigenetic changes is crucial for deciphering ALL pathogenesis.

Purpose of the Study:

• To analyze and integrate methylome and transcriptome profiles in pediatric B-cell ALL.
• To identify genes with concurrent DNA methylation and gene expression changes in ALL subtypes.
• To investigate the role of epigenetic deregulation in pediatric B-cell ALL.

Main Methods:

• Analysis and integration of methylome and transcriptome data from pediatric B-cell ALL cases and primary tissue controls.
• Identification of differentially methylated and expressed genes across ALL subtypes.
• Correlation of specific epigenetic alterations with genetic translocations and chromosomal abnormalities.

Main Results:

• 325 genes were found to be hypermethylated and downregulated, while 45 genes were hypomethylated and upregulated in pediatric B-cell ALL, irrespective of subtype.
• Overrepresentation of repressed cation channel subunits and cAMP signaling components suggests impaired apoptotic signaling.
• Specific epigenetic alterations were linked to genetic subtypes: ETV6-RUNX1 translocation associated with ASNS downregulation and EPO-receptor upregulation; Hyperdiploid ALL associated with BCL member upregulation and PTPRG/FHIT repression.

Conclusions:

• Genome-wide epigenetic deregulation is a common feature across all pediatric B-cell ALL subtypes.
• Genetically distinct B-cell ALL subtypes harbor cooperative epimutations.
• These findings highlight the complex interplay between genetic and epigenetic alterations in pediatric ALL development and progression.